Canada Diabetes Market Report: 2018-2023

  • ID: 4535144
  • Report
  • Region: Canada
  • 78 pages
  • IMARC Group
1 of 3
This new report “Canada Diabetes Market Report: 2018-2023” provides an analytical and statistical insight into the Canada diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Canada. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Canada diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Canada diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Canada diabetes epidemiology and its dynamics:

Focus of the analysis:

Historical, current and future prevalence of diabetes in Canada
Historical, current and future prevalence of type-1 and type-2 diabetes in Canada
Historical, current and future prevalence of diabetes in the urban and rural regions in Canada
Historical, current and future prevalence of diabetes among males and females in Canada
Historical, current and future prevalence of diabetes among various age groups in Canada
Historical, current and future diagnosis rates for diabetes in Canada
Historical, current and future drug treatment rates for diabetes in Canada

Comprehensive situation analysis of the Canadian Oral Antidiabetics market and its dynamics:

Focus of the analysis:

Performance of the Oral Antidiabetics market in Canada
Performance of key classes
Performance of key players
Market outlook

Comprehensive situation analysis of the Canadian Insulin market and its dynamics:

Focus of the analysis:

Performance of the Insulin market in Canada
Performance of key classes
Performance of key players
Market outlook
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications

6 Canada Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group

7 Canada Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Strengths
7.4.2 Weaknesses
7.4.3 Opportunities
7.4.4 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 Canada Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 Canada Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast

8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll